Allucent is a global contract research organization (CRO) that provides drug development solutions and consulting services to small and mid-sized biotech companies. Operating across more than 60 countries, the company draws on over 30 years of collective experience in regulatory affairs, therapeutic development, and clinical operations to guide clients from early-stage innovation through to regulatory approval.
Its core service areas span the full drug development lifecycle:
- Consulting: Regulatory and therapeutic strategy informed by experience in regulatory trends and therapeutic development
- Clinical operations: Execution and management of clinical trials
- Biometrics: Statistical analysis, programming, and data management for clinical studies
- Clinical pharmacology: Pharmacokinetics, pharmacodynamics, dose selection, and related studies
Allucent focuses on complex and challenging therapeutic areas, including oncology, hematology, neuroscience, immunology, infectious disease, cardiometabolic diseases, cell and gene therapy, rare diseases, and pediatric trials. Its model is designed specifically around the operational and regulatory challenges facing smaller biotech organizations, rather than the larger pharmaceutical companies that many CROs primarily serve.
